• “花冠模式”演绎鲁酒特色的崛起之道 2019-10-22
  • 【理上网来喜迎十九大】增强思想上的团结统一 2019-10-13
  • 候选企业:安徽古井集团 2019-10-13
  • 科学恢复森林 广汽丰田用心守护自然家园 2019-10-11
  • 的确如此。报刊亭取消的确是短视行为。把报刊亭设计的现代化一些,与城市绿化衔接起来,相得益彰,成为文化一景多好。 2019-10-11
  • 切切切,端午节安康! 2019-10-10
  • 男人公共场合“石更”了怎么办?丨叨可特先生 2019-09-30
  • 对手的表扬是最好的批评 2019-09-26
  • 细读“文艺复兴” 透过贝利尼家族的收藏史看大展 2019-09-25
  • 坚持全球视野、开放理念、市场导向加快推进人才高地基础上的人才高峰建设 2019-09-21
  • 百姓故事:蒋姐姐的旗袍人生 2019-09-17
  • 习近平总书记文化思想的实践指向 2019-09-17
  • 宜春通报7起作风问题典型案例 2019-09-12
  • 珠海举行军民两用技术应用推广对接会 2019-09-09
  • 社评:中国打的是对美贸易自卫反击战 2019-09-09
  • About Us

    Shanghai Shyndec Pharmaceutical Co.,Ltd,

    Shanghai Shyndec Pharmaceutical Co.,Ltd, which was established in 1996, is a high-tech enterprise in the pharmaceutical industry which is specialized in manufacturing new drug preparation products and founded by academician of Chinese Academy of Engineering. It was listed on Shanghai stock exchange on June 16, 2004 (stock code: 600420, stock abbreviation:现代制药). In April 2010, it entered China National Pharmaceutical Group Corporation(SINOPHARM).

    In 2016-2017, according to the integration strategy ofSINOPHARM, Shanghai Shyndec Pharmaceutical Co.,Ltd positioned itself as a pharmaceutical industry platform of SINOPHARM, have actively promoted major asset restructuring matters. The main business of the "new Shyndec " wholly-owned or holding subsidiary after the reorganization has achieved nearly 10 billion level of revenue, total profit has exceeded 1 billion yuan, and the number of enterprise members has reached 30, among which 17 are secondary enterprises, 13 are tertiary and four-level enterprises.

    After the reorganization, the "New Shyndec" has integrated into many high-quality industrial product lines and enterprise assets of China National Pharmaceutical Group to create a more centralized resource allocation and a clearer main business market. Focusing on the "anti-infection, cardiovascular and cerebrovascular, anti-tumor, leptin drugs, metabolism and endocrine" five areas then has formed and strengthened the "5 + X" industrial chain system with the modern characteristics and core competitiveness of Chinese medicine. The product structure of the company will be richer, the R&D strength will be further strengthened, and the market position of the enterprise has been improved by leaps and bounds.

    For a year, Shanghai Shyndec Pharmaceutical Co.,Ltd has been guided by "big reorganization, large integration, great amalgamation and fully development". Through the three main paths of " big reorganization of institutional framework, great amalgamation of ideology and culture, great integration of personnel assets" to achieve the development goal of large-scale integration of the group chemical pharmaceutical industry and strive to create a platform of chemical pharmaceutical industry under the guidance of innovation.

    • Stock Code

      600420

    • Stock Abbreviation

      现代制药

    • Company Address:

      Building 1, No. 1320, west Beijing road, Shanghai

    Organizational Structure

  • “花冠模式”演绎鲁酒特色的崛起之道 2019-10-22
  • 【理上网来喜迎十九大】增强思想上的团结统一 2019-10-13
  • 候选企业:安徽古井集团 2019-10-13
  • 科学恢复森林 广汽丰田用心守护自然家园 2019-10-11
  • 的确如此。报刊亭取消的确是短视行为。把报刊亭设计的现代化一些,与城市绿化衔接起来,相得益彰,成为文化一景多好。 2019-10-11
  • 切切切,端午节安康! 2019-10-10
  • 男人公共场合“石更”了怎么办?丨叨可特先生 2019-09-30
  • 对手的表扬是最好的批评 2019-09-26
  • 细读“文艺复兴” 透过贝利尼家族的收藏史看大展 2019-09-25
  • 坚持全球视野、开放理念、市场导向加快推进人才高地基础上的人才高峰建设 2019-09-21
  • 百姓故事:蒋姐姐的旗袍人生 2019-09-17
  • 习近平总书记文化思想的实践指向 2019-09-17
  • 宜春通报7起作风问题典型案例 2019-09-12
  • 珠海举行军民两用技术应用推广对接会 2019-09-09
  • 社评:中国打的是对美贸易自卫反击战 2019-09-09
  • 快速时时秘籍 重庆时时彩怎么作弊的 pk10 1期6码如何倍投 体育比分最新开奖查询 赚钱咯稳包平特一肖 如何代理棋牌 精准免费彩票计划软件11远5 电子游艺pt平台 包胆是什么意思啊 体球网足球即时比分